A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC). (2021)

Record Type:: Journal Article
Title:: A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC). (2021)
Main Title:: A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC)
Authors:: Nassabein, Rami
Gaudreau, Pierre-Olivier
Belkaid, Wiam
Florescu, Marie
Blais, Normand
Abstract:
Is Part Of:: Cancer treatment and research communications. Number 28(2021)
Journal:: Cancer treatment and research communications
Issue:: Number 28(2021)
Issue Display:: Volume 28, Issue 28 (2021)
Year:: 2021
Volume:: 28
Issue:: 28
Issue Sort Value:: 2021-0028-0028-0000
Page Start:
Page End:
Publication Date:: 2021
Journal URLs:: http://www.sciencedirect.com/ ↗
DOI:: 10.1016/j.ctarc.2021.100421 ↗
Languages:: English
ISSNs:: 2468-2942
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 18492.xml